
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy
Keywords: NO; nitric oxide; DMD; Duchenne muscular dystrophy; NCX 320; 4-(nitrooxy)butyl 2-(4-isobutylphenyl)propanoate; CINOD; cyclooxygenase inhibiting nitric oxide donator; nNOS; neuronal nitric oxide synthase; LPS; lipopolysaccharide from Escherichia coli; PGE2